Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Illumivaption Inc. d/b/a Nashville Vapor
WARNING LETTER
•Illumivaption Inc. d/b/a Nashville Vapor•October 7, 2021

Illumivaption Inc. d/b/a Nashville Vapor – FDA Warning Letter, Oct 7, 2021

Record Details

The FDA Center for Tobacco Products issued a Warning Letter to David Pellicane regarding e-liquid products sold on nashvillevapor.com. The FDA determined that products like Sancia Tiger Blood 30ml and Sancia Banana Nut Bread 30ml are "new tobacco products" under section 201(rr) of the FD&C Act, subject to FDA jurisdiction.

These products are deemed adulterated under section 902(6)(A) and misbranded under section 903(a)(6) of the FD&C Act because they were not commercially marketed in the U.S. as of February 15, 2007, and lack the required premarket authorization order or exemption. The firm, a registered manufacturer with over 800 products listed with FDA, had a Premarket Tobacco Product Application (PMTA) (STN PM0003569) for 771 products, which received a Marketing Denial Order on September 3, 2021.

The FDA emphasizes that all new tobacco products on the market without premarket authorization are unlawful and subject to enforcement actions, including civil money penalties, seizure, and/or injunction. The company must submit a written response within 15 working days detailing actions taken to address violations, including discontinuing sales and a plan for future compliance.

Company
Illumivaption Inc. d/b/a Nashville Vapor
Inspection date
October 7, 2021
Product type
Tobacco
Office
Center for Tobacco Products
People
  • Ann Simoneau (Director)
  • Peter Toumbekis
  • David Pellicane
  • Robert Preston Warfield
View Company Profile

ID · 5398df73-add3-41be-af96-9eecc8a57d6f

Violation Codes10
21 U.S.C. 321(rr)21 U.S.C. 387a(b)21 CFR 1100.121 U.S.C. 387j(a)21 U.S.C. 387j(c)(1)(A)(i)21 U.S.C. 387e(j)21 U.S.C. 387e(j)(1)(A)(ii)21 U.S.C. 387e(j)(3)21 U.S.C. 30121 CFR 1140

Full citation text and observation details available on the Dashboard.

Other documents for Illumivaption Inc. d/b/a Nashville Vapor
  • WARNING_LETTER - 2023-08-10August 10, 2023

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Illumivaption Inc. d/b/a Nashville Vapor
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.